DD144050A5 - Verfahren zur herstellung von n-alkylierten aminoalkoholen - Google Patents

Verfahren zur herstellung von n-alkylierten aminoalkoholen Download PDF

Info

Publication number
DD144050A5
DD144050A5 DD79213267A DD21326779A DD144050A5 DD 144050 A5 DD144050 A5 DD 144050A5 DD 79213267 A DD79213267 A DD 79213267A DD 21326779 A DD21326779 A DD 21326779A DD 144050 A5 DD144050 A5 DD 144050A5
Authority
DD
German Democratic Republic
Prior art keywords
hydroxy
phenoxy
aminomethyl
carbamoyl
item
Prior art date
Application number
DD79213267A
Other languages
German (de)
English (en)
Inventor
Franz Ostermayer
Markus Zimmermann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD144050A5 publication Critical patent/DD144050A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
DD79213267A 1978-06-05 1979-05-30 Verfahren zur herstellung von n-alkylierten aminoalkoholen DD144050A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH613678 1978-06-05

Publications (1)

Publication Number Publication Date
DD144050A5 true DD144050A5 (de) 1980-09-24

Family

ID=4304840

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79213267A DD144050A5 (de) 1978-06-05 1979-05-30 Verfahren zur herstellung von n-alkylierten aminoalkoholen

Country Status (26)

Country Link
US (1) US4460580A (es)
EP (1) EP0005848B1 (es)
JP (1) JPS54163543A (es)
KR (4) KR840000926B1 (es)
AR (3) AR229022A1 (es)
AT (1) ATE511T1 (es)
AU (1) AU522483B2 (es)
CA (1) CA1124241A (es)
CY (1) CY1256A (es)
DD (1) DD144050A5 (es)
DE (1) DE2961669D1 (es)
DK (1) DK229879A (es)
ES (1) ES481238A1 (es)
FI (1) FI791727A (es)
GB (1) GB2026474B (es)
GR (1) GR74057B (es)
HK (1) HK15585A (es)
HU (1) HU182019B (es)
IL (1) IL57471A (es)
MY (1) MY8500690A (es)
NO (1) NO149034C (es)
NZ (1) NZ190632A (es)
PL (5) PL117155B1 (es)
PT (1) PT69723A (es)
SG (1) SG45884G (es)
ZA (1) ZA792748B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965655D1 (en) * 1978-06-28 1983-07-21 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
EP0021840B1 (en) * 1979-06-29 1983-08-31 Glaxo Group Limited Heterocyclic compounds, processes for their preparation and compositions containing them
DD157796A5 (de) * 1979-12-04 1982-12-08 Ciba Geigy Ag Verfahren zur herstellung neuer derivate des 2-amino-aethanols
JPS5726653A (en) * 1980-05-09 1982-02-12 Ciba Geigy Ag Substituted phenyl ether
DE3026534A1 (de) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
GR74992B (es) * 1980-08-13 1984-07-12 Ciba Geigy Ag
JPS57185243A (en) * 1981-05-08 1982-11-15 Ciba Geigy Ag Substituted 2-aminoethanol
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
FR2543139B1 (fr) * 1983-03-22 1985-08-16 Cerm Cent Europ Rech Mauvernay Derives de (1-alcoxy 2-amino) ethyl pyridine ou pyrazine, leur preparation et leur application en therapeutique
DE3608290A1 (de) * 1986-03-13 1987-09-24 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3621775A1 (de) * 1986-03-13 1988-01-07 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA1287061C (en) * 1986-06-27 1991-07-30 Roche Holding Ltd. Pyridine ethanolamine derivatives
GB8714901D0 (en) * 1986-07-23 1987-07-29 Ici Plc Amide derivatives
DE3627663A1 (de) * 1986-08-14 1988-03-03 Bayer Ag Heteroarylethylamine, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer bei tieren
US5108363A (en) * 1988-02-19 1992-04-28 Gensia Pharmaceuticals, Inc. Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
GB8925032D0 (en) * 1989-11-06 1989-12-28 Ici Plc Chemical compounds
JPH0466934A (ja) * 1990-07-04 1992-03-03 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US5232948A (en) * 1990-09-10 1993-08-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
ATE312347T1 (de) * 1991-08-23 2005-12-15 Nps Pharma Inc Screening-verfahren für kalzium-rezeptor aktive verbindungen
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5208252A (en) * 1992-07-24 1993-05-04 Ortho Pharmaceutical Corporation Aminoethylthiophene derivatives
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
WO1995019336A1 (de) * 1994-01-12 1995-07-20 Iovis Biomedical And Pharmaceutical Consultants Phenylethanolaminether und ihre verwendung als beta-adrenorezeptor-agonisten
DE122005000033I2 (de) 1994-10-21 2006-11-23 Nps Pharma Inc Kalzium-Receptor aktive Verbindungen
PT907631E (pt) 1996-05-01 2003-10-31 Nps Pharma Inc Compostos inorganicos activos como receptores de ioes
KR100380520B1 (ko) * 2000-09-08 2003-04-23 한국화학연구원 피리딘을 포함한 β-아미노알코올 유도체
WO2003090251A1 (en) * 2002-04-22 2003-10-30 Koninklijke Philips Electronics N.V. Luminescent screen
US7538141B2 (en) * 2004-03-23 2009-05-26 Alan Daniel Brown Compounds for the treatment of diseases
MX2012010364A (es) * 2010-03-08 2013-02-26 Univ Tennessee Res Foundation Antagonistas de los receptores beta-adrenérgicos y usos de los mismos.
ITMI20122221A1 (it) * 2012-12-21 2014-06-22 C4T S C A R L Nuovi composti del 2,3-diidro-4h-1,3-benzossazin-4-one, metodo per prepararli e forma farmaceutica che li comprende
CN104008939B (zh) * 2014-06-19 2016-05-11 苏州普京真空技术有限公司 一种耐用电子枪灯丝

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1178400A (en) * 1966-12-13 1970-01-21 Delalande Sa Nitrogen Substituted Amines and their process of Preparation.
DE1543538A1 (de) * 1966-12-30 1976-02-05 Degussa Verfahren zur herstellung neuer heterocyclischer aminoalkohole
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
GB1301134A (en) * 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES
GB1398738A (en) * 1972-12-05 1975-06-25 Pfizer Ltd Propanolamine derivatives
US4082772A (en) * 1975-04-18 1978-04-04 American Home Products Corporation Thiophene ethanolamines
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines

Also Published As

Publication number Publication date
CA1124241A (en) 1982-05-25
GB2026474B (en) 1982-07-14
ZA792748B (en) 1980-06-25
KR830000679A (ko) 1983-04-18
AU4773679A (en) 1979-12-13
FI791727A (fi) 1979-12-06
NO149034B (no) 1983-10-24
KR830000681A (ko) 1983-04-18
EP0005848B1 (de) 1981-12-30
DE2961669D1 (en) 1982-02-18
MY8500690A (en) 1985-12-31
HU182019B (en) 1983-12-28
CY1256A (en) 1984-11-23
NO791841L (no) 1979-12-06
DK229879A (da) 1979-12-06
PL116529B1 (en) 1981-06-30
NO149034C (no) 1984-02-01
PL216090A1 (es) 1980-03-24
GR74057B (es) 1984-06-06
PT69723A (de) 1979-07-01
US4460580A (en) 1984-07-17
KR830000680A (ko) 1983-04-18
JPS54163543A (en) 1979-12-26
PL116612B1 (en) 1981-06-30
SG45884G (en) 1985-03-08
HK15585A (en) 1985-03-15
PL117158B1 (en) 1981-07-31
GB2026474A (en) 1980-02-06
NZ190632A (en) 1984-07-06
AR229951A1 (es) 1984-01-31
PL116597B1 (en) 1981-06-30
IL57471A (en) 1982-11-30
AU522483B2 (en) 1982-06-10
KR840000926B1 (ko) 1984-06-29
ATE511T1 (de) 1982-01-15
PL117155B1 (en) 1981-07-31
AR229022A1 (es) 1983-05-31
ES481238A1 (es) 1980-02-16
AR229581A1 (es) 1983-09-30
EP0005848A1 (de) 1979-12-12

Similar Documents

Publication Publication Date Title
DD144050A5 (de) Verfahren zur herstellung von n-alkylierten aminoalkoholen
EP0004920B1 (de) Carbazolyl-(4)-oxy-propanolamin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD150456A5 (de) Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
US4034009A (en) 4-Ureido-2-acyl phenoxypropanolamine
EP0375791A1 (de) Neue Phenylethanolamine, deren Verwendung als Arzneimittel und als Leistungsförderer bei Tieren sowie Verfahren zu ihrer Herstellung
DE1922003C3 (de) N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz
EP0192829B1 (de) Amino-propanol-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel sowie Zwischenprodukte
EP0124476A1 (de) Carboxamide, Verfahren zur Herstellung und pharmazeutische Präparate, die diese enthalten
DE3114239A1 (de) "piperazinderivate"
US4914202A (en) Morpholine compounds
FR2460294A1 (fr) Nouveaux oxime-ethers, leur procede de preparation et compositions pharmaceutiques les contenant
DE3014813A1 (de) 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)benzoesaeure-derivate
US4041074A (en) 1-Hydroxyaryl-2-amidoalkylaminoethanol derivatives
FR2651227A1 (fr) Nouveaux derives de l'aminopropanol, procede pour leur preparation et compositions pharmaceutiques contenant de tels derives.
US4450172A (en) Antihypertensive polyhalohydroxyisopropyl phenylalka(e)noic acid esters of alkylaminohydroxypropyloxyphenylalkyl alcohols
EP0101380A2 (fr) Nicotinamide 1-oxyde N-substitué, ses sels, procédé pour leur préparation et compositions pharmaceutiques en contenant
CH655721A5 (fr) Derives du furanne et sels d'addition de ces derives leurs procedes de preparation et composition pharmaceutique les contenant.
FR2755439A1 (fr) Derives aryloxypropanolamines, leur procede de preparation et leurs applications
CA1210392A (fr) Procede pour la preparation d'amides n-substitues, et les amides ainsi obtenus
EP0030030A1 (de) Derivate des 2-Amino-äthanols, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend solche Verbindungen und Verwendung von letzteren
DE2540552A1 (de) Cycloalkylderivate von 1-aryloxy-3- amino-2-propanolen
DE2324584A1 (de) Neue amine und verfahren zu ihrer herstellung
DD202286A5 (de) Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
EP0069838A1 (de) Aralkylaminoethoxysalicylamide und deren pharmazeutische Verwendung
DE2229241A1 (de) Alkanolamiderivate